Literature DB >> 28399385

Adjuvant Chemotherapy for Stage II Colon Cancer: The Debate Goes On.

James J Lee1, Edward Chu1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28399385      PMCID： PMC5455155          DOI： 10.1200/JOP.2017.022178

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  7 in total

1.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

Authors:  Dung T Le; Jennifer N Uram; Hao Wang; Bjarne R Bartlett; Holly Kemberling; Aleksandra D Eyring; Andrew D Skora; Brandon S Luber; Nilofer S Azad; Dan Laheru; Barbara Biedrzycki; Ross C Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Steven M Duffy; Richard M Goldberg; Albert de la Chapelle; Minori Koshiji; Feriyl Bhaijee; Thomas Huebner; Ralph H Hruban; Laura D Wood; Nathan Cuka; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; Shibin Zhou; Toby C Cornish; Janis M Taube; Robert A Anders; James R Eshleman; Bert Vogelstein; Luis A Diaz
Journal:  N Engl J Med       Date:  2015-05-30       Impact factor: 91.245

Review 2.  Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma.

Authors:  Joseph Kannarkatt; Joe Joseph; Peter C Kurniali; Anas Al-Janadi; Borys Hrinczenko
Journal:  J Oncol Pract       Date:  2017-04       Impact factor: 3.840

Review 3.  Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group.

Authors:  Alvaro Figueredo; Manya L Charette; Jean Maroun; Melissa C Brouwers; Lisa Zuraw
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

4.  In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

Authors:  Franck Pagès; Amos Kirilovsky; Bernhard Mlecnik; Martin Asslaber; Marie Tosolini; Gabriela Bindea; Christine Lagorce; Philippe Wind; Florence Marliot; Patrick Bruneval; Kurt Zatloukal; Zlatko Trajanoski; Anne Berger; Wolf-Herman Fridman; Jérôme Galon
Journal:  J Clin Oncol       Date:  2009-10-26       Impact factor: 44.544

5.  Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

Authors:  Daniel Sargent; Alberto Sobrero; Axel Grothey; Michael J O'Connell; Marc Buyse; Thierry Andre; Yan Zheng; Erin Green; Roberto Labianca; Chris O'Callaghan; Jean Francois Seitz; Guido Francini; Daniel Haller; Greg Yothers; Richard Goldberg; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2009-01-05       Impact factor: 44.544

6.  Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.

Authors:  Jeanne Tie; Yuxuan Wang; Cristian Tomasetti; Lu Li; Simeon Springer; Isaac Kinde; Natalie Silliman; Mark Tacey; Hui-Li Wong; Michael Christie; Suzanne Kosmider; Iain Skinner; Rachel Wong; Malcolm Steel; Ben Tran; Jayesh Desai; Ian Jones; Andrew Haydon; Theresa Hayes; Tim J Price; Robert L Strausberg; Luis A Diaz; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Peter Gibbs
Journal:  Sci Transl Med       Date:  2016-07-06       Impact factor: 17.956

7.  Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

Authors:  Richard Gray; Jennifer Barnwell; Christopher McConkey; Robert K Hills; Norman S Williams; David J Kerr
Journal:  Lancet       Date:  2007-12-15       Impact factor: 79.321
  7 in total
  8 in total

1.  Treating Colorectal Cancer with Immunotherapy: Implications for Single versus Combination Therapy.

Authors:  Sophiya Karki; Shahid Umar; Anup Kasi
Journal:  Curr Colorectal Cancer Rep       Date:  2020-08-20

2.  Perineural invasion is a prognostic factor in stage II colorectal cancer but not a treatment indicator for traditional chemotherapy: a retrospective cohort study.

Authors:  Juan Li; Shiwen Mei; Sichen Zhou; Fuqiang Zhao; Qian Liu
Journal:  J Gastrointest Oncol       Date:  2022-04

3.  Prognostic value of the ratio of carcinoembryonic antigen concentration to maximum tumor diameter in patients with stage II colorectal cancer.

Authors:  Xianzhe Li; Zhizhong Xiong; Minghao Xie; Qunsheng Huang; Longyang Jin; Shi Yin; Shuanggang Chen; Ping Lan; Lei Lian
Journal:  J Gastrointest Oncol       Date:  2021-08

4.  Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer.

Authors:  Xianzhe Li; Minghao Xie; Shi Yin; Zhizhong Xiong; Chaobin Mao; Fengxiang Zhang; Huaxian Chen; Longyang Jin; Ping Lan; Lei Lian
Journal:  Front Genet       Date:  2021-05-04       Impact factor: 4.599

Review 5.  Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature.

Authors:  Burcin Baran; Nazli Mert Ozupek; Nihal Yerli Tetik; Emine Acar; Omer Bekcioglu; Yasemin Baskin
Journal:  Gastroenterology Res       Date:  2018-02-08

6.  Expanding the TNM for cancers of the colon and rectum using machine learning: a demonstration.

Authors:  Matthew Hueman; Huan Wang; Donald Henson; Dechang Chen
Journal:  ESMO Open       Date:  2019-06-12

Review 7.  Cancer combination therapies by angiogenesis inhibitors; a comprehensive review.

Authors:  Mohammad Javed Ansari; Dmitry Bokov; Alexander Markov; Abduladheem Turki Jalil; Mohammed Nader Shalaby; Wanich Suksatan; Supat Chupradit; Hasan S Al-Ghamdi; Navid Shomali; Amir Zamani; Ali Mohammadi; Mehdi Dadashpour
Journal:  Cell Commun Signal       Date:  2022-04-07       Impact factor: 5.712

8.  Prognostic significance of additional histologic features for subclassification of pathological T3 colon cancer.

Authors:  Lorenzo Macchi; Quoc Riccardo Bao; Laura Albertoni; Matteo Fassan; Valentina Chiminazzo; Marco Scarpa; Gaya Spolverato; Salvatore Pucciarelli
Journal:  Int J Clin Oncol       Date:  2022-06-18       Impact factor: 3.850
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.